-- Preview Email Newsletter
*New Hampshire Editor Tipoffs Newsletter for 2024-12-28 ( 9 items ) |
FDA Announces Reorganization of Office of Medical Policy to Advance Clinical Trial Innovation (10)
WASHINGTON, Dec. 22 (TNSFR) -- The Food and Drug Administration (FDA) has revealed a reorganization within its Center for Drug Evaluation and Research (CDER), specifically within the Office of Medical Policy (OMP), aimed at enhancing the agency's capacity to address emerging challenges in clinical trials. Approved by the Secretary of Health and Human Services on November 19, 2024, the restructuring is designed to modernize clinical trial processes and integrate advanced technologies into drug de more PR
FDA Proposes Revisions to Opioid Treatment Drug Labeling Amid Concerns Over Dosage Misinterpretation (10)
WASHINGTON, Dec. 27 (TNSFR) -- The U.S. Food and Drug Administration (FDA) has announced plans to revise specific statements in the labeling of buprenorphine-containing transmucosal products used for treating opioid dependence (BTODs). The agency aims to address concerns that the current language, which refers to "target" dosages and specifies no clinical advantage for dosages higher than 24 mg per day, may inadvertently mislead healthcare providers and restrict patient access to appropriate tre more PR
FDA Proposes Rule for Asbestos Testing in Talc-Containing Cosmetics (10)
WASHINGTON, Dec. 27 (TNSFR) -- The Food and Drug Administration (FDA) has proposed a rule to mandate standardized testing methods for detecting asbestos in talc-containing cosmetic products. The initiative addresses public health concerns associated with asbestos contamination, a known carcinogen linked to serious illnesses such as mesothelioma and ovarian cancer. The proposed regulations aim to enhance consumer safety by requiring manufacturers to adopt advanced testing protocols.
Under the ru more PR
FDA Releases Public Communication From Protecting Access to Pain Relief (10)
WASHINGTON, Dec. 27 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated Dec. 20, 2024, from the Protecting Access to Pain Relief:
* * *
To: Dr. Theresa Michele, M.D.
Division of Nonprescription Drug Products
Center for Drug Evaluation and Research
Food and Drug Administration
10903 New Hampshire Ave., Bldg. 22, Rm. 5491
Silver Spring, MD 20993-0002
RE: Reauthorization of the Over-The-Counter Monograph Drug more ST
FDA Releases Public Communication From Public Access to SunScreen Coalition (10)
WASHINGTON, Dec. 27 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated Dec. 20, 2024, from Michael Werner, policy advisor at the Public Access to SunScreen Coalition:
* * *
To: Dr. Theresa Michele, M.D.
Division of Nonprescription Drug Products
Center for Drug Evaluation and Research
Food and Drug Administration
10903 New Hampshire Ave., Bldg. 22, Rm. 5491
Silver Spring, MD 20993-0002
RE: Reauthorization more ST
Hassan-Backed Bipartisan Bill to Support Autism Research (10)
WASHINGTON, Dec. 28 -- Sen. Maggie Hassan, D-New Hampshire, issued the following news release:
A bipartisan bill, backed by U.S. Senator Maggie Hassan, to support autism education, research, and resources has been signed into law. The Autism CARES Act of 2024 renews and expands federal support for research, services, and training related to autism spectrum disorder and other developmental disabilities. Senator Hassan, a member of the Senate Health, Education, Labor, & Pensions (HELP) Committee, more PR
N.H. PUC Issues Order Involving Liberty Utilities (10)
CONCORD, New Hampshire, Dec. 28 -- The New Hampshire Public Utilities Commission issued the following electric order (No. 27,091) on Dec. 27, 2024, involving Liberty Utilities (Granite State Electric) Corp.:
* * *
2024 Default Service Solicitations
Order Approving Petition for February 1, 2025 to July 31, 2025 Rates
This order authorizes Liberty Utilities (Granite State Electric) Corp. d/b/a Liberty (Liberty or the Company) to recover the costs of power supply through default energy service more PR
Senate Homeland Security & Governmental Affairs Committee Issues Testimony From Postmaster General DeJoy (Part 3 of 3) (10)
WASHINGTON, Dec. 27 -- The Senate Homeland Security and Governmental Affairs Committee released the following written testimony by Louis DeJoy, postmaster general and CEO of the U.S. Postal Service, from a Dec. 5, 2024, hearing entitled "Oversight of the United States Postal Service: Understanding Proposed Service Changes":
* * *
(Continued from Part 2 of 3)
Growth and cost reduction are at the heart of the DFA plan. Simply put, the DFA plan is not about contraction or only cost reduction. Th more PR
South Dakota unemployment rate 1.9 percent in November 2024 (10)
WASHINGTON, Dec. 26 (TNSres) -- The U.S. Department of Labor's Bureau of Labor Statistics issued the following document from Economics Daily:
* * *
In November 2024, South Dakota had the lowest unemployment rate, 1.9 percent. Eight other states (North Dakota, Vermont, New Hampshire, Nebraska, Hawaii, Wisconsin, Connecticut, and Virginia) also had unemployment rates that were 3.0 percent or lower.
Nevada had the highest unemployment rate, 5.7 percent, followed by the District of Columbia, 5.6 more PR
|